Related Experiment Videos
Surgical salvage for recurrent "early" glottic cancers
T Maipang1, M S Razack, K Sako
1Department of Head and Neck Surgery, Roswell Park Memorial Institute, Buffalo, NY 14263.
Journal of Surgical Oncology
|January 1, 1989
Summary
This study on early glottic cancer found radiation therapy offers good initial cure rates. Surgical salvage provides a high success rate for recurrent tumors, improving overall survival for glottic cancer patients.
Area of Science:
- Otolaryngology
- Radiation Oncology
- Surgical Oncology
Background:
- Early glottic cancer (T1 and T2 N0) requires effective treatment strategies.
- Understanding recurrence patterns after initial therapy is crucial for patient management.
- Cervical lymph node metastasis is a key prognostic factor in glottic cancer.
Purpose of the Study:
- To evaluate recurrence rates after primary radiation therapy for early glottic cancer.
- To determine the efficacy of surgical salvage for recurrent glottic cancer.
- To analyze the incidence of cervical lymph node metastases in this patient cohort.
Main Methods:
- Retrospective analysis of 143 patients with early glottic cancer over 25 years.
- Data collection on initial radiation therapy outcomes.
- Review of surgical salvage procedures and outcomes for recurrent disease.
Main Results:
- Initial radiation therapy achieved 5-year cure rates of 78% for stage I and 57% for stage II glottic cancer.
- Total laryngectomy for recurrent squamous cell carcinoma yielded 5-year salvage rates of 66% (stage I) and 61% (stage II).
- Overall 5-year cure rates, including initial and salvage therapy, were 93% for stage I and 83% for stage II.
Conclusions:
- Radiation therapy is an effective primary treatment for early glottic cancer.
- Surgical salvage offers a high success rate for managing recurrent glottic cancer.
- Combined initial and salvage therapies significantly improve long-term cure rates for early glottic cancer.